Table Of Contents
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT
5.1 DIAGNOSTIC
5.2 THERAPEUTICS
5.3 MEDICAL CARE
5.4 NUTRITION AND WELLNESS
5.5 OTHERS
6. U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION
6.1 DIAGNOSIS AND INTERVENTION
6.3 DRUG DEVELOPMENT AND USAGE
6.4 CANCER GENOMICS
6.5 OTHERS
7. U.S. PERSONALISED MEDICINE MARKET, BY END USERS
7.1 HOSPITALS
7.2 MOLECULAR DIAGNOSTIC LABORATORIES AND TESTING CENTERS
7.3 ACADEMIC INSTITUTES
7.4 BIO AND HEALTH INFORMATICS COMPANIES
7.4 OTHERS
8. U.S. PERSONALISED MEDICINE MARKET, BY REGION
8.1 U.S.
8.1.1 INTRODUCTION
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9..1.1 STRATEGIC PARTNERSHIP
9..1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 ABBOTT
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 BECTON DICKINSON & CO.,
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 GE HEALTHCARE
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 LABORATORY CORPORATION OF AMERICA
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 PFIZER
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 OTHERS
List Of Tables
TABLE 1 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 2 U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 3 U.S. PERSONALISED MEDICINE MARKETBY END USERS 2020-2027 (USD MILLION)
TABLE 4 U.S. PERSONALISED MEDICINE MARKET, BY REGION 2020-2027 (USD MILLION)
List Of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 U.S. PERSONALISED MEDICINE MARKET, BY PRODUCT
FIGURE 4 U.S. PERSONALISED MEDICINE MARKET, BY APPLICATION
FIGURE 5 U.S. PERSONALISED MEDICINE MARKET, BY END USERS
FIGURE 6 U.S. PERSONALISED MEDICINE MARKET, BY REGION
FIGURE 7 U.S. PERSONALISED MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2020